Home/Filings/4/0001127602-11-031523
4//SEC Filing

McCullough David 4

Accession 0001127602-11-031523

CIK 0000882796other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 2:41 PM ET

Size

4.7 KB

Accession

0001127602-11-031523

Insider Transaction Report

Form 4
Period: 2011-12-07
Transactions
  • Sale

    Common Stock

    2011-12-07$2.85/sh4,542$12,9456,000 total
Footnotes (1)
  • [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.84 to $2.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001395238

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 2:41 PM ET
Size
4.7 KB